The company
BioMarin Pharmaceutical Inc.
BMRN · Nasdaq
BMRN stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 6.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $8.6M
- Officials’ trades on record
- 22
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
22 disclosed lines: House 21, Senate 0, executive 1; 9 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 17 Apr 2026filed 1 Jul 2026 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 6 Mar 2023filed 17 Apr 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | sold | $1k–$15k | 18 Oct 2021filed 15 Nov 2021 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39 | bought | $15k–$50k | 30 Dec 2020filed 11 Jan 2021 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 16 Oct 2020filed 5 Nov 2020 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | sold | $1k–$15k | 15 Sep 2020filed 13 Oct 2020 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 16 Dec 2019filed 6 Jan 2020 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 11 Dec 2019filed 6 Jan 2020 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $1k–$15k | 15 Aug 2019filed 1 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $1k | 15 Aug 2019filed 1 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $1k–$15k | 14 Aug 2019filed 1 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $0k | 14 Aug 2019filed 1 Sep 2019 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| George Eric DavisEVP, Chief Legal Officer | sold | 17,557at $66.28 | 2 Sep 2026filed 3 Sep 2026 |
| Gregory R. FribergEVP, Chief R&D Officer | sold | 3,281at $53.85 | 7 May 2026filed 11 May 2026 |
| Charles Greg GuyerEVP, Chief Technical Officer | sold | 16,486at $60.46 | 11 Mar 2026filed 12 Mar 2026 |
| George Eric DavisEVP, Chief Legal Officer | sold | 26,061at $61.36 | 26 Feb 2026filed 26 Feb 2026 |
| Gregory R. FribergEVP, Chief R&D Officer | sold | 6,326at $60.38 | 26 Feb 2026filed 26 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.